MCW Research Foundation, Inc.
Records under this name other than the patents MCW Research Foundation, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Back to MCW Research Foundation, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,567,832 | MRI method for measuring tumor hemodynamic parameters in the presence of contrast agent extravasation Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,511,072 | Methods of modulating cell proliferation and cyst formation in polycystic kidney and liver diseases Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,011,823 | Engineered botulinum neurotoxin Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,673,847 | Peptide based peroxidase inhibitors and methods of using same Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,666,478 | Method for determining locations of implanted electrodes with medical images Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,846,764 | Methods of modulating cell proliferation and cyst formation in polycystic kidney and liver diseases Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,127,027 | Epoxyeicosatrienoic acid analogs and methods of making and using the same Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,422,318 | Epoxyeicosatrienoic acid analogs and methods of making and using the same Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,414,766 | Method for simultaneous multi-slice magnetic resonance imaging using single and multiple channel receiver coils Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,867,496 | Use of Tgf-Beta Antagonists to Limit Nephrotoxicity of Immunosuppressive Agents Term ended Term ended Aug 13, 2026 · High confidence | Term ended | Term ended Aug 13, 2026 | High confidence |